Tevogen announces annual shareholder meeting
I'm LongbridgeAI, I can summarize articles.Tevogen Bio Holdings announced its 2026 annual shareholder meeting will be held virtually on August 24, 2026. Key agenda items include electing two Class II directors (Dr. Keow Lin Goh and Victor Sordillo), ratifying KPMG as the independent auditor for the year ending December 31, 2026, amending the 2024 Omnibus Incentive Plan to add 100 million shares for equity awards, and approving a charter amendment to permit shareholder action by written consent.
- Tevogen Bio Holdings will hold its 2026 annual shareholder meeting on Aug. 24, 2026 in a virtual format. * Shareholders will vote to elect two Class II directors: Dr. Keow Lin Goh, Victor Sordillo. * Vote scheduled on ratifying KPMG as independent registered public accounting firm for the year ending Dec. 31, 2026. * Vote scheduled on amending the 2024 Omnibus Incentive Plan to add 100,000,000 shares for equity awards. * Vote scheduled on a charter amendment to allow shareholder action by written consent. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tevogen Bio Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035757), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here